Skip to main content

Table 1 Demographic, anthropometry and clinical characteristics

From: Assessing the feasibility of injectable growth-promoting therapy in Crohn’s disease

  Total n = 48 (80%)
Age/year (range) 14.3 (7.0, 17.7)
Sex (M), n (%) 35 (73)
HtSDS (range) −1.2 (−3.01, 0.89)
MPHSDS (range) −0.59 (−3.14, 1.4)
Treated for growth problem, n (%) 4 (8)
Family history of CD, n (%) 8 (17)
  1. MPHSDS mid-parental height SDS, HtSDS height SDS score, CD Crohn’s disease
\